Drugs & Targets FDA grants Breakthrough Device designation to Natera’s Signatera test May 10, 2019Vol.45 No.19
Drugs & Targets Caris Life Sciences receives FDA Breakthrough Device designation for MI Transcriptome companion diagnostic test May 10, 2019Vol.45 No.19
Drugs & Targets European Commission approves Lorviqua in previously-treated ALK-positive advanced NSCLC May 10, 2019Vol.45 No.19
Drugs & Targets Arcus Biosciences and Strata Oncology announce clinical development collaboration for anti-PD-1 antibody May 10, 2019Vol.45 No.19
Clinical Roundup BMS phase III study didn’t meet primary endpoint of OS with Opdivo + radiation in glioblastoma multiforme May 10, 2019Vol.45 No.19
Clinical Roundup City of Hope opens multiple myeloma autologous CAR T-cell therapy trial targeting CS1 protein May 10, 2019Vol.45 No.19
Funding Opportunities DoD Breast Cancer Research Program– funding opportunities for FY19 May 10, 2019Vol.45 No.19
Funding Opportunities DoD Prostate Cancer Research Program– opportunities for FY19 May 10, 2019Vol.45 No.19
In Brief Primo “Lucky” Lara now serves as SWOG deputy chair, Kathy Albain is vice president May 10, 2019Vol.45 No.19
